Aegerion (AEGR) Clinical Update on Its Lomitapide

  • Uploaded by Karmastock on Jan 8, 2012
  • Views: 154
Aegerion Pharmaceuticals Incorporated - AEGR - provided a clinical update on its lomitapide. Aegerion reported that the 78-week data from its pivotal Phase III clinical trial is consistent with data previously reported at the 26- and 56-week time points

Aegerion Pharmaceuticals Incorporated - AEGR - provided a clinical update on its lomitapide. Aegerion reported that the 78-week data from its pivotal Phase III clinical trial is consistent with data previously reported at the 26- and 56-week time points

Categories:
Show More Show Less
Comments